A Controlled Trial of Erenumab in Migraine Prevention
Status:
Completed
Trial end date:
2020-11-25
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess the efficacy and safety of erenumab for prevention of
migraine in Japanese adults with episodic migraine (EM) and chronic migraine (CM).